Look back at pharma news in the week to May 14, 2021

Avacopan's chances in hidradenitis suppurativa and C3 glomerulopathy look like a long shot after mid-stage failures last year; ChemoCentryx also …

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *